About this Journal

Dermatologic Therapy was founded a quarter century ago to enhance an important area in the dermatologic literature with an authoritative, scholarly source of the latest information on the treatment of diseases that affect the skin, hair, nails or accessible mucous membranes. The journal maintains an international focus of interest to a wide readership. 

Dermatologic Therapy invites submissions of applicable original research articles and reviews. The priorities for publication highlight scientific merit, originality, and salience to academia and the medical community. With dermatological treatments evolving rapidly, disseminating notable information and advancing knowledge in relevant areas is crucial to Dermatologic Therapy’s mission.

The purview of Dermatologic Therapy includes prospective, retrospective, case-controlled, longitudinal and randomized controlled trials as well as various treatment modalities, novel techniques and instruments, and safety and efficacy studies.

This journal is published by Hindawi as part of a publishing collaboration with John Wiley & Sons, Inc. It is a fully open access journal produced under the Hindawi and Wiley brands. 

ISSN: 1396-0296 (Print) 

ISSN: 1529-8019 (Online) 

DOI: 10.1155/dth  

Content published prior to 2023 is hosted on the Wiley Online Library.

Dermatologic Therapy is an open access journal. All articles are immediately available to read and reuse upon publication. More information about our Open Access policy can be found on our copyright page.

Editorial enquiries should be directed to dth@hindawi.com.

General enquiries should be directed to help@hindawi.com.